The pathophysiology of DMD in skeletal muscle has been conceptualized in our laboratory as a two-phase process (Figure 7) that helps contextualize the structural consequences of repeated injury in dystrophin-deficient muscle [5,12,47,54,60,88]. This evidence concerns the gene DMD and Duchenne muscular dystrophy.